Poster: AACR (American Association for Cancer Research), April 5-10, 2024, San Diego CA
A systemically delivered, clinically-ready, attenuated Salmonella Typhimurium strain ACTM-838 alters the tumor microenvironment and provides durable anti-tumor activity in vivo VIEW POSTER PDF
Article Date
April 8, 2024
This article is featured on another website.
Go to article
July 15, 2026
Glioblastoma Clinical Trials – Where Progress is Actually Happening in Glioma Research
Where Glioma Research Is Actually Moving Forward Glioblastoma (GBM) is the most common and most…
July 15, 2026
Glioblastoma Clinical Trials – Where Progress is Actually Happening in Glioma Research
Where Glioma Research Is Actually Moving Forward Glioblastoma (GBM) is the most common and most…
September 11, 2026
Data Governance and Geopolitics: The New Operational Reality of Global Clinical Trials
Part 4 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
September 11, 2026
Data Governance and Geopolitics: The New Operational Reality of Global Clinical Trials
Part 4 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…